...
首页> 外文期刊>Angewandte Chemie >Rotaxanes as Cages to Control DNA Binding, Cytotoxicity, and Cellular Uptake of a Small Molecule**
【24h】

Rotaxanes as Cages to Control DNA Binding, Cytotoxicity, and Cellular Uptake of a Small Molecule**

机译:转子作为笼子控制DNA结合,细胞毒性和小分子的细胞吸收**

获取原文
获取原文并翻译 | 示例
           

摘要

The efficacy of many drugs can be limited by undesirable properties, such as poor aqueous solubility, low bioavailability, and "off-target" interactions. To combat this, various drug carriers have been investigated to enhance the pharmacological profile of therapeutic agents. In this work, we demonstrate the use of mechanical protection to "cage" a DNA-targeting metallodrug within a photodegradable rotaxane. More specifically, we report the synthesis of rotaxanes incorporating as a stoppering unit a known G-quadruplex DNA binder, namely a Pt-II-salphen complex. This compound cannot interact with DNA when it is part of the mechanically interlocked assembly. The second rotaxane stopper can be cleaved by either light or an esterase, releasing the Pt-II-salphen complex. This system shows enhanced cell permeability and limited cytotoxicity within osteosarcoma cells compared to the free drug. Light activation leads to a dramatic increase in cytotoxicity, arising from the translocation of Pt-II-salphen to the nucleus and its binding to DNA.
机译:许多药物的疗效可能会受到不良特性的限制,例如水溶性差、生物利用度低和“脱靶”相互作用。为了解决这个问题,人们研究了各种药物载体,以增强治疗药物的药理学特性。在这项工作中,我们展示了使用机械保护将DNA靶向金属药物“笼”在光降解轮烷中。更具体地说,我们报告了以已知的G-四链体DNA粘合剂,即Pt II salphen复合物作为止动单元的轮烷的合成。当这种化合物是机械联锁组件的一部分时,它不能与DNA相互作用。第二个轮烷塞可以被光或酯酶切割,释放Pt II salphen复合物。与游离药物相比,该系统显示骨肉瘤细胞内的细胞通透性增强,细胞毒性有限。光激活导致细胞毒性显著增加,这是由于Pt II salphen转移到细胞核并与DNA结合而引起的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号